Microglia—the brain's immune cells—undergo metabolic shifts with age that correlate with chronic inflammation and increased risk of neurodegenerative disease. These metabolic changes are reversible targets for intervention, offering a mechanistic pathway to slow cognitive decline and protect against Alzheimer's and Parkinson's disease.
Key Points
- Microglial metabolism directly determines immune function and inflammatory output
- Metabolic reprogramming during aging shifts toward chronic neuroinflammation patterns
- Sex-specific metabolic differences suggest personalized therapeutic approaches are necessary
Longevity Analysis
The aging brain does not simply decline—it undergoes systematic metabolic reprogramming at the cellular level that drives neuroinflammation and accelerates degeneration. Rather than treating neurodegeneration as inevitable, this research identifies the metabolic substrate driving it. Interventions that restore appropriate microglial metabolic function address a root mechanism of cognitive aging itself, not merely its symptoms. Understanding how energy production pathways shift in aging microglia creates opportunities to decode harmful signals the immune system is generating and correct them before they compromise neurological function.
Original published by Wiley Aging Cell, by Seokjo Kang, Helen S. Goodridge .